Loading...

Nachrichtenliste

Huatangning, the world's first new hypoglycemic drug was approved

2022-10-09


Huatangning, the world's first new hypoglycemic drug was approved

Beijing, Oct. 9, 2022 -- Bayer announced that the global initiative for state and drug administration approved the diabetes drug ITO ning (Glenn YiTing), used alone, or in a separate use of metformin hydrochloride poor blood sugar control, and used in combination with metformin hydrochloride, cooperate with diet and exercise to improve glycemic control in adults with type 2 diabetes. Huatangning is a product cooperation between Bayer and Hualing Medicine in the field of diabetes treatment. It's the first glucokinase activator drug approved in the world.

Wir möchten Cookies verwenden, um Ihre Nutzung dieser Website besser zu verstehen und Ihre Erfahrung bei zukünftigen Besuchen der Website zu verbessern. Sie können diese Einstellung in Ihren Browsereinstellungen ändern. Weitere Informationen zur Verwendung von Cookies finden Sie in unserer Datenschutzrichtlinie.